
The article details two options strategies for Biogen (BIIB), currently trading at $130.97, aimed at yield enhancement or discounted share acquisition. Selling a $130.00 strike put for a $3.70 premium offers a 2.85% return (24.16% annualized) if it expires worthless, or an effective purchase price of $126.30 if assigned. Alternatively, a covered call at the $132.00 strike with a $4.40 premium yields a 4.15% return by September 5th if shares are called away, or a 3.36% premium boost (28.52% annualized) if it expires worthless, with both options exhibiting approximately 37% implied volatility against the stock's 29% trailing volatility.
The analysis centers on two specific options strategies for Biogen (BIIB), currently trading at $130.97 per share, highlighting opportunities for yield generation or discounted stock acquisition. A cash-secured put strategy at the $130.00 strike price offers a potential entry point at an effective cost basis of $126.30, a discount to the current market price. Alternatively, if the out-of-the-money put expires worthless, which has a stated probability of 56%, the seller would realize a 2.85% return on the cash commitment, equivalent to a 24.16% annualized yield. For current shareholders, a covered call strategy at the $132.00 strike provides a potential total return of 4.15% if the stock is called away by the September 5th expiration. If the call expires worthless, an event with a 48% probability, the premium offers a 3.36% return boost, or 28.52% annualized. A key data point is the significant spread between the options' implied volatility of approximately 37% and the stock's trailing twelve-month historical volatility of 29%. This premium in implied volatility indicates that options are currently priced for larger price swings than have occurred historically, making option-selling strategies comparatively more attractive.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment